Save Search
Save your searches to access them later
Saved Searches
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Reset All
Filter Icon Filter 1
Search Paper
Cancel
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Reset All
Filter Icon Filter 1
Export
Sort by: Relevance
  • New
  • Research Article
  • 10.1016/j.jcyt.2025.10.007
A FOXP3+ cell-rich microenvironment associates with better overall survival after CAR-T cell therapy in relapsed/refractory B-cell lymphoma
  • Nov 1, 2025
  • Cytotherapy
  • S Zanella + 11 more

  • Research Article
  • 10.1016/j.jcyt.2025.10.004
Single-Cell Transcriptomics Reveals Dynamics of NK Cell Expansion in a Feeder Cell-Free Culture of PBMCs - Implications for Immunotherapy
  • Oct 1, 2025
  • Cytotherapy
  • Brian Ladd + 5 more

  • Research Article
  • 10.1016/j.jcyt.2025.09.013
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
  • Oct 1, 2025
  • Cytotherapy
  • Alexandra Dreyzin + 32 more

  • Research Article
  • 10.1016/j.jcyt.2025.10.003
Pilot study of early BK polyomavirus in the urine and risk of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
  • Oct 1, 2025
  • Cytotherapy
  • Yeon Joo Lee + 10 more

  • Research Article
  • 10.1016/j.jcyt.2025.10.001
A differentiated and durable allogeneic strategy applicable to cell therapies.
  • Oct 1, 2025
  • Cytotherapy
  • Utsav Jetley + 16 more

  • Research Article
  • 10.1016/j.jcyt.2025.09.010
Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experience.
  • Oct 1, 2025
  • Cytotherapy
  • Seungwon An + 11 more

  • Research Article
  • 10.1016/j.jcyt.2025.09.011
Comparison of stem cell mobilization methods in multiple myeloma.
  • Oct 1, 2025
  • Cytotherapy
  • Yutaka Shimazu + 19 more

  • Research Article
  • 10.1016/j.jcyt.2025.10.006
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
  • Oct 1, 2025
  • Cytotherapy
  • Jonida Kokiçi + 19 more

  • Research Article
  • 10.1016/j.jcyt.2025.09.012
Unrelated donor transplantation offers a real curative opportunity for patients with transfusion-dependent thalassaemia. A multicenter retrospective study on behalf of the Spanish group for hematopoietic transplantation and cellular therapy (GETH-TC).
  • Oct 1, 2025
  • Cytotherapy
  • María Isabel Benítez-Carabante + 13 more

  • Research Article
  • 10.1016/j.jcyt.2025.10.008
Brain on the Mend: iMSC-Based Therapies Promote Functional Recovery in Rats with Neonatal Hypoxic-Ischemic Brain Injury
  • Oct 1, 2025
  • Cytotherapy
  • Inês Serrenho + 3 more